Shogo Shigeta

No ORCID on file · 6 papers in corpus
diagnostic-accuracy 2026
Journal of translational medicine ·doi:10.1186/s12967-026-08539-7

BACKGROUND: Early detection of epithelial ovarian cancer (EOC) remains a major clinical challenge. Although serum tumor markers are widely used for detection, their diagnostic performance remains limited. We previously developed a comprehen…

case-report 2026
Journal of medical case reports ·doi:10.1186/s13256-026-06317-z

BACKGROUND: Peritoneal defects of the broad ligament of the uterus are uncommon anatomical abnormalities that may be congenital or acquired. Situs inversus totalis is a congenital condition characterized by a complete mirror-image arrangeme…

other 2025
International journal of molecular sciences ·doi:10.3390/ijms26125435

Epithelial ovarian cancer (EOC) is diagnosed at an advanced stage in over half of the patients and its prognosis remains unfavorable. CA125, one of the most frequent positive tumor markers in patients with EOC, has certain limitations. Ther…

diagnostic-accuracy 2023
Current oncology (Toronto, Ont.) ·doi:10.3390/curroncol30090597

BACKGROUND: Endometrial cancer is one of the most common gynecological malignancies. Because the findings mentioned in radiogram interpretation reports issued by diagnostic radiologists influence treatment strategies, we aimed to evaluate t…

other 2021
Gynecologic oncology reports ·doi:10.1016/j.gore.2021.100847

OBJECTIVE: Ovarian cancer (OC) is an intractable gynecological tumor, and frequent recurrence is experienced within a few years even after the complete eradication of tumor tissues by radical resection and neo-adjuvant chemotherapies. The c…

lab-animal 2021
Molecular cancer therapeutics ·doi:10.1158/1535-7163.mct-20-0809

Ovarian clear cell carcinoma (OCCC) is a rare, chemo-resistant subtype of ovarian cancer. To identify novel therapeutic targets and combination therapies for OCCC, we subjected a set of patient-derived ovarian cancer cell lines to arrayed h…